These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 28385948)

  • 21. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
    Mehra MR; Netuka I; Uriel N; Katz JN; Pagani FD; Jorde UP; Gustafsson F; Connors JM; Ivak P; Cowger J; Ransom J; Bansal A; Takeda K; Agarwal R; Byku M; Givertz MM; Bitar A; Hall S; Zimpfer D; Vega JD; Kanwar MK; Saeed O; Goldstein DJ; Cogswell R; Sheikh FH; Danter M; Pya Y; Phancao A; Henderson J; Crandall DL; Sundareswaran K; Soltesz E; Estep JD;
    JAMA; 2023 Dec; 330(22):2171-2181. PubMed ID: 37950897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design Rationale and Preclinical Evaluation of the HeartMate 3 Left Ventricular Assist System for Hemocompatibility.
    Bourque K; Cotter C; Dague C; Harjes D; Dur O; Duhamel J; Spink K; Walsh K; Burke E
    ASAIO J; 2016; 62(4):375-83. PubMed ID: 27195742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
    Mehra MR; Crandall DL; Gustafsson F; Jorde UP; Katz JN; Netuka I; Uriel N; Connors JM; Sood P; Heatley G; Pagani FD
    Eur J Heart Fail; 2021 Jul; 23(7):1226-1237. PubMed ID: 34142415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-Term Outcomes of Magnetically Levitated Left Ventricular Assist Device in Advanced Heart Failure　- The Japanese Cohort.
    Inoue K; Fujita T; Yoshioka D; Tonai K; Yanagino Y; Kakuta T; Tadokoro N; Kawamoto N; Yamashita K; Kawamura A; Matsuura R; Kawamura T; Saito T; Kawamura M; Kainuma S; Fukushima S; Toda K; Miyagawa S
    Circ J; 2022 Nov; 86(12):1961-1967. PubMed ID: 36273915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of pump replacement on outcome in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Artif Organs; 2013 Jul; 37(7):606-14. PubMed ID: 23692322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
    John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First experiences with HeartMate 3 follow-up and adverse events.
    Hanke JS; Dogan G; Rojas SV; Zoch A; Feldmann C; Deniz E; Avsar M; Warnecke G; Haverich A; Schmitto JD
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):173-178. PubMed ID: 28268010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants.
    Mehra MR; Cleveland JC; Uriel N; Cowger JA; Hall S; Horstmanshof D; Naka Y; Salerno CT; Chuang J; Williams C; Goldstein DJ;
    Eur J Heart Fail; 2021 Aug; 23(8):1392-1400. PubMed ID: 33932272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device Among Women and Men.
    Ramu B; Cogswell R; Ravichandran AK; Cleveland J; Mehra MR; Goldstein D; Uriel N; Dirckx N; Ahmed S; Yuzefpolskaya M
    JACC Heart Fail; 2023 Dec; 11(12):1692-1704. PubMed ID: 37831046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
    Uriel N; Milano C; Agarwal R; Lee S; Cleveland J; Goldstein D; Wang A; Crandall D; Mehra MR
    Eur J Heart Fail; 2023 Feb; 25(2):286-294. PubMed ID: 36404406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study.
    Netuka I; Ivák P; Tučanová Z; Gregor S; Szárszoi O; Sood P; Crandall D; Rimsans J; Connors JM; Mehra MR
    J Heart Lung Transplant; 2018 May; 37(5):579-586. PubMed ID: 29655662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.
    John R; Naka Y; Park SJ; Sai-Sudhakar C; Salerno C; Sundareswaran KS; Farrar DJ; Milano CA
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):581-9; discussion 589. PubMed ID: 24418362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device.
    Sidhu K; Lam PH; Mehra MR
    Trends Cardiovasc Med; 2020 May; 30(4):223-229. PubMed ID: 31201005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States.
    Imamura T; Ono M; Kinugawa K; Fukushima N; Shiose A; Matsui Y; Yamazaki K; Saiki Y; Usui A; Niinami H; Matsumiya G; Arai H; Sawa Y; Uriel N
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183082
    [No Abstract]   [Full Text] [Related]  

  • 39. Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.
    Schmitto JD; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Sood P; Damme L; Netuka I
    Eur J Heart Fail; 2019 Jan; 21(1):90-97. PubMed ID: 30052304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
    Nayak A; Hall SA; Uriel N; Goldstein DJ; Cleveland JC; Cowger JA; Salerno CT; Naka Y; Horstmanshof D; Crandall D; Wang A; Mehra MR
    J Am Coll Cardiol; 2023 Aug; 82(9):771-781. PubMed ID: 37612008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.